In this episode of From Lab to Launch by Qualio we interview Joseph Mossel, CEO and co-founder of Ibex Medical Analytics. Joseph shares his journey from computer science to leading a transformative AI-driven company in pathology. Founded in 2016, Ibex aims to provide accurate, timely, and personalized cancer diagnoses using AI technology. Joseph discusses the challenges and insights from deploying AI in clinical settings, the importance of partnerships, and the company's vision for the next few years. Tune in to learn how Ibex's innovations are reshaping cancer diagnostics and making a significant impact on patient outcomes.https://ibex-ai.com/ https://www.linkedin.com/in/yossimossel/ 00:00 Introduction to the Podcast00:26 Meet Joseph Mossel, CEO of Ibex01:14 The Founding and Vision of Ibex05:59 Ibex's AI Technology and Its Impact07:41 Challenges and Overcoming Them09:54 AI in Cancer Diagnostics15:12 Future of AI in Pathology17:15 Partnerships and Collaborations19:58 Advice for Labs and Entrepreneurs23:29 Ensuring AI Reliability and Quality25:48 Fun and Final Thoughts Qualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez

Ver todos los episodios